Table 2 . 2Overlapping pathways for targets of SM cocktails and OSKM.Pathways

Cocktails

#1

#2

#3

#4

#5

#6

#7

#8

#9

#10

Pathways in cancer

Chronic myeloid leukemia

Prostate cancer

Bladder cancer

Small cell lung cancer *

Viral carcinogenesis

HTLV

I infection

Hepatitis B

Epstein

Barr virus infection

p53 signaling pathway

Dark gray color with (*) depicts overlaps with p < 0.05. Light gray depicts the pathways with insignificant overlaps (p > 0.05).

Table 3 . 3SMs as human metabolites.Name Role in induced cell reprogramming (inducer/enhancer) Chemical class

5'

Azacytidine (5'

azaC)

Enhancer

Nucleotides and nucleotide derivatives

5'

Aza

2'

deoxycytidine

Enhancer

Nucleotides and nucleotide derivatives

7

hydroxyflavone

Enhancer

Flavonoids

90

D3 (Vitamin D3)

Enhancer

Steroids and steroid derivatives

Apigenin

Enhancer

Flavonoids

Caffeic acid

Putative enhancer or inducer

Cinnamic acids and derivatives

Chlorogenic acid

Putative enhancer or inducer

Fatty acids and derivatives

Curcumin

Enhancer

Diarylheptanoids

Dasatinib

Inducer

Benzene and derivatives

Dexamethasone

Enhancer

Steroids and steroid derivatives

EGCG

Enhancer

Flavonoids

Fisetin

Enhancer

Flavonoids

Forskolin

Inducer

Benzofurans

Fru

2,6

P2

Enhancer

Organooxygen compounds

Luteolin

Enhancer

Flavonoids

N

acetyl

cysteine

Enhancer

Amino acids and derivatives

Sodium Butyrate (NaB)

Inducer and enhancer

Fatty acids and derivatives

Prostaglandin E2

Enhancer

Fatty acids and derivatives

Quercetin

Enhancer

Flavonoids

Rapamycin

Enhancer

Macrolide lactams

Resveratrol

Enhancer

Stilbenes

Retinoic acid

Enhancer

Prenol lipids

SAHA

Enhancer

Benzene and derivatives

Spermidine

Enhancer

Organonitrogen compounds

Valproic acid

Inducer

Fatty acids and derivatives

Vitamin A (Retinol acetate)

Enhancer

Prenol lipids

Vitamin C (Ascorbic acid; Ascorbate) Enhancer Dihydrofurans

Zolpidem

Enhancer

Azoles

enrichment = 5, p < 2.0E-

Cocktail 5 (BrdUC6F)Cocktail 6 (VC6TF + AM 580 + EPZ004777) Cocktail 7 (VC6TF + AM580 + DZNep + 5-aza-dC + SGC0946 + EPZ004777) SMs and their protein targets.Cocktail 9 (VC6TF + AM 580 + DZNep)BrdU CHIR99021 RepSox Forskolin

VPA

CHIR99021

RepSox

Parnate

Forskolin

AM 580

EPZ004777

VPA

CHIR99021

RepSox

Parnate

Forskolin

AM 580

DZNep

5

aza

dC

SGC0946

EPZ004777

Cocktail 8 (VC6TF + DZNep)

VPA

CHIR99021

AGING

RepSOX

Parnate

Forskolin

DZNep

VPA

CHIR99021

RepSox

Parnate

Forskolin

AM 580

DZNep

Cocktail 10 (CNɑATP)

CHIR99021

NaB

cyclic pifithrin

a (ɑ)

A

83

01

Thiazovivin

PD0325901

The role of DNA damage and repair in aging through the prism of Koch-like criteria. A A Moskalev, M V Shaposhnikov, E N Plyusnina, A Zhavoronkov, A Budovsky, H Yanai, V E Fraifeld, 10.1016/j.arr.2012.02.00122353384Ageing Res Rev. 12Moskalev AA, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Yanai H, Fraifeld VE. The role of DNA damage and repair in aging through the prism of Koch-like criteria. Ageing Res Rev. 2013; 12:661-84. https://doi.org/10.1016/j.arr.2012.02.001 PMID:22353384

A multidimensional systems biology analysis of cellular senescence in aging and disease. R A Avelar, J G Ortega, R Tacutu, E J Tyler, D Bennett, P Binetti, A Budovsky, K Chatsirisupachai, Johnson E Murray, A Shields, S Tejada-Martinez, D Thornton, D , 10.1186/s13059-020-01990-9Genome Biol. 2132264951Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, Budovsky A, Chatsirisupachai K, Johnson E, Murray A, Shields S, Tejada-Martinez D, Thornton D, et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 2020; 21:91. https://doi.org/10.1186/s13059-020-01990-9 PMID:32264951

iPSCs-Induced Cellular Reprogramming. Encyclopedia of Biomedical Gerontology. K K Muradian, V E Fraifeld, Academic PressMuradian KK, Fraifeld VE. iPSCs-Induced Cellular Reprogramming. Encyclopedia of Biomedical Gerontology. Academic Press. 2020; 291-8.

. 10.1016/B978

0

12

801238

3.11299

1https://doi.org/10.1016/B978

0

12

801238

3.11299

1

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. K Takahashi, S Yamanaka, 10.1016/j.cell.2006.07.02416904174Cell. 126Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126:663-76. https://doi.org/10.1016/j.cell.2006.07.024 PMID:16904174

Induction of pluripotent stem cells from adult human fibroblasts by defined factors. K Takahashi, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda, S Yamanaka, 10.1016/j.cell.2007.11.01918035408Cell. 131Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131:861-72. https://doi.org/10.1016/j.cell.2007.11.019 PMID:18035408

The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Y Buganim, S Markoulaki, N Van Wietmarschen, H Hoke, T Wu, K Ganz, B Akhtar-Zaidi, Y He, B J Abraham, D Porubsky, E Kulenkampff, D A Faddah, L Shi, Cell Stem Cell. 15Buganim Y, Markoulaki S, van Wietmarschen N, Hoke H, Wu T, Ganz K, Akhtar-Zaidi B, He Y, Abraham BJ, Porubsky D, Kulenkampff E, Faddah DA, Shi L, et al. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell. 2014; 15:295-309.

. 10.1016/j.stem.2014.07.00325192464https://doi.org/10.1016/j.stem.2014.07.003 PMID:25192464

Induced pluripotent stem cell lines derived from human somatic cells. J Yu, M A Vodyanik, K Smuga-Otto, Antosiewicz- Bourget, J Frane, J L Tian, S Nie, J Jonsdottir, G A Ruotti, V Stewart, R Slukvin, I I Thomson, J A , 10.1126/science.115152618029452Science. 318Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318:1917-20. https://doi.org/10.1126/science.1151526 PMID:18029452

Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. J Liao, Z Wu, Y Wang, L Cheng, C Cui, Y Gao, T Chen, L Rao, S Chen, N Jia, H Dai, S Xin, J Kang, 10.1038/cr.2008.5118414447Cell Res. 18Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen S, Jia N, Dai H, Xin S, Kang J, et al. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res. 2008; 18:600-3. https://doi.org/10.1038/cr.2008.51 PMID:18414447

. P Hou, Y Li, X Zhang, C Liu, J Guan, H Li, T Zhao, J Ye, Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, www.aging-us.com AGING

Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds. W Yang, K Liu, J Ge, J Xu, Q Zhang, 10.1126/science.123927823868920Science. 341Yang W, Liu K, Ge J, Xu J, Zhang Q, et al. Pluripotent stem cells induced from mouse somatic cells by small- molecule compounds. Science. 2013; 341:651-4. https://doi.org/10.1126/science.1239278 PMID:23868920

Generation of neural progenitor cells by chemical cocktails and hypoxia. L Cheng, W Hu, B Qiu, J Zhao, Y Yu, W Guan, M Wang, W Yang, G Pei, 10.1038/cr.2014.3224638034Cell Res. 24Cheng L, Hu W, Qiu B, Zhao J, Yu Y, Guan W, Wang M, Yang W, Pei G. Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res. 2014; 24:665-79. https://doi.org/10.1038/cr.2014.32 PMID:24638034

Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. J Ye, J Ge, X Zhang, L Cheng, Z Zhang, S He, Y Wang, H Lin, W Yang, J Liu, Y Zhao, H Deng, Cell Res. 26Ye J, Ge J, Zhang X, Cheng L, Zhang Z, He S, Wang Y, Lin H, Yang W, Liu J, Zhao Y, Deng H. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Cell Res. 2016; 26:34-45.

. 10.1038/cr.2015.14226704449https://doi.org/10.1038/cr.2015.142 PMID:26704449

The triumph of chemically enhanced cellular reprogramming: a patent review. M A Anwar, S Kim, S Choi, 10.1517/13543776.2016.111805826593376Expert Opin Ther Pat. 26Anwar MA, Kim S, Choi S. The triumph of chemically enhanced cellular reprogramming: a patent review. Expert Opin Ther Pat. 2016; 26:265-80. https://doi.org/10.1517/13543776.2016.1118058 PMID:26593376

Chemical reprogramming and transdifferentiation. X Xie, Y Fu, J Liu, 10.1016/j.gde.2017.07.00328755566Curr Opin Genet Dev. 46Xie X, Fu Y, Liu J. Chemical reprogramming and transdifferentiation. Curr Opin Genet Dev. 2017; 46:104-13. https://doi.org/10.1016/j.gde.2017.07.003 PMID:28755566

Chemical-induced cardiac reprogramming in vivo. C Huang, W Tu, Y Fu, J Wang, X Xie, 10.1038/s41422-018-0036-4Cell Res. 2829670223Huang C, Tu W, Fu Y, Wang J, Xie X. Chemical-induced cardiac reprogramming in vivo. Cell Res. 2018; 28:686-9. https://doi.org/10.1038/s41422-018-0036-4 PMID:29670223

The role of the Hedgehog signaling pathway in cancer: A comprehensive review. A M Skoda, D Simovic, V Karin, V Kardum, S Vranic, L Serman, 10.17305/bjbms.2018.275629274272Bosn J Basic Med Sci. 18Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn J Basic Med Sci. 2018; 18:8-20. https://doi.org/10.17305/bjbms.2018.2756 PMID:29274272